| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.65 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |